Your one stop place for all the latest ReGen Factor news and updates on progress with product developments, FDA trials, ASX listing, Industry News and Scientific Studies.
Prioritizing FDA applications for diabetic ulcers and diabetic retinopathy using their recombinant human basic Fibroblast Growth Factor (rh bFGF). This shift addresses substantial unmet medical
NEWS PROVIDED BY ReGen Factor Pty Ltd August 02, 2022, 22:01 GMT SHARE THIS ARTICLE ReGen Factor and MedSpa Equip UK have partnered to expand
ReGen Factor Commence Cosmetic Trials ReGen Factor commenced stage 1 cosmetic trials to prove the effectiveness of PepFactor Scalp for hair regrowth. The test will
FDA Consultants to join with ReGen Factor We are excited to announce the appointment of a leading FDA consulting group headquartered in Phoenix, Arizona as
Hair restoration and anti-aging skin treatments ReGen Factor offers hair restoration and anti-aging skin treatment solutions to med-spa owners, medical practitioners, DOs, RNs, and aesthetic
